$ATOM
Atomera Inc

2023 Q4 Form 10-Q Financial Statement

#000168316823007564 Filed on November 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $550.0K $0.00
YoY Change 10900.0% -100.0%
Cost Of Revenue $28.00K $0.00
YoY Change
Gross Profit $522.0K $0.00
YoY Change 10340.0% -100.0%
Gross Profit Margin 94.91%
Selling, General & Admin $2.327M $2.048M
YoY Change 23.25% 7.0%
% of Gross Profit 445.79%
Research & Development $2.992M $3.305M
YoY Change 18.59% 20.49%
% of Gross Profit 573.18%
Depreciation & Amortization $293.0K $310.0K
YoY Change -5.48% 1531.58%
% of Gross Profit 56.13%
Operating Expenses $5.319M $5.353M
YoY Change 20.58% 14.95%
Operating Profit -$4.797M -$5.353M
YoY Change 8.87% 14.99%
Interest Expense $152.0K $47.00K
YoY Change 13.43% -21.67%
% of Operating Profit
Other Income/Expense, Net $65.00K $314.0K
YoY Change 492.45%
Pretax Income -$4.580M -$5.040M
YoY Change 7.21% 9.52%
Income Tax
% Of Pretax Income
Net Earnings -$4.580M -$5.039M
YoY Change 7.21% 9.5%
Net Earnings / Revenue -832.73%
Basic Earnings Per Share -$0.20
Diluted Earnings Per Share -$0.18 -$0.20
COMMON SHARES
Basic Shares Outstanding 25.80M shares 25.79M shares
Diluted Shares Outstanding 25.26M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.53M $20.39M
YoY Change -7.8% -12.44%
Cash & Equivalents $12.59M $12.64M
Short-Term Investments $6.940M $7.750M
Other Short-Term Assets $244.0K $390.0K
YoY Change -41.63% -34.67%
Inventory
Prepaid Expenses
Receivables $550.0K
Other Receivables $79.00K
Total Short-Term Assets $20.40M $20.84M
YoY Change -5.55% -12.76%
LONG-TERM ASSETS
Property, Plant & Equipment $100.0K $129.0K
YoY Change -36.71% -21.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $105.0K $110.0K
YoY Change 0.0% 4.76%
Total Long-Term Assets $3.625M $3.992M
YoY Change -29.3% -27.09%
TOTAL ASSETS
Total Short-Term Assets $20.40M $20.84M
Total Long-Term Assets $3.625M $3.992M
Total Assets $24.03M $24.83M
YoY Change -10.1% -15.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $618.0K $462.0K
YoY Change 55.67% -11.83%
Accrued Expenses $222.0K $230.0K
YoY Change 28.32% 12.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.328M $1.300M
YoY Change 17.94% 24.64%
Total Short-Term Liabilities $3.814M $2.951M
YoY Change 31.16% 4.94%
LONG-TERM LIABILITIES
Long-Term Debt $1.750M $2.070M
YoY Change -41.39% -36.39%
Other Long-Term Liabilities $295.0K $350.0K
YoY Change -43.38% -43.0%
Total Long-Term Liabilities $2.045M $2.420M
YoY Change -41.69% -37.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.814M $2.951M
Total Long-Term Liabilities $2.045M $2.420M
Total Liabilities $5.859M $5.365M
YoY Change -8.67% -19.69%
SHAREHOLDERS EQUITY
Retained Earnings -$203.1M -$198.5M
YoY Change 10.8% 10.88%
Common Stock $221.3M $218.0M
YoY Change 8.67% 8.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $18.17M $19.46M
YoY Change
Total Liabilities & Shareholders Equity $24.03M $24.83M
YoY Change -10.1% -15.43%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$4.580M -$5.039M
YoY Change 7.21% 9.5%
Depreciation, Depletion And Amortization $293.0K $310.0K
YoY Change -5.48% 1531.58%
Cash From Operating Activities -$2.907M -$3.480M
YoY Change -0.38% 17.33%
INVESTING ACTIVITIES
Capital Expenditures $1.000K $10.00K
YoY Change -92.31% -242.86%
Acquisitions
YoY Change
Other Investing Activities $880.0K $3.250M
YoY Change
Cash From Investing Activities $879.0K $3.240M
YoY Change -6861.54% -46385.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.985M -30.00K
YoY Change 139.73% -100.68%
NET CHANGE
Cash From Operating Activities -2.907M -3.480M
Cash From Investing Activities 879.0K 3.240M
Cash From Financing Activities 1.985M -30.00K
Net Change In Cash -43.00K -270.0K
YoY Change -97.96% -118.63%
FREE CASH FLOW
Cash From Operating Activities -$2.907M -$3.480M
Capital Expenditures $1.000K $10.00K
Free Cash Flow -$2.908M -$3.490M
YoY Change -0.78% 17.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001420520
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37850
dei Entity Registrant Name
EntityRegistrantName
ATOMERA INCORPORATED
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-0509586
dei Entity Address Address Line1
EntityAddressAddressLine1
750 University Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 280
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Gatos
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95032
dei City Area Code
CityAreaCode
(408)
dei Local Phone Number
LocalPhoneNumber
442-5248
dei Security12b Title
Security12bTitle
Common stock: Par value $0.001
dei Trading Symbol
TradingSymbol
ATOM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25799018 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12642000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21184000 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
7747000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2023Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
56000 usd
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
0 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
392000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
418000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
20837000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
21602000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
129000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
158000 usd
CY2023Q3 ATOM Longterm Prepaid Maintenance And Supplies
LongtermPrepaidMaintenanceAndSupplies
91000 usd
CY2022Q4 ATOM Longterm Prepaid Maintenance And Supplies
LongtermPrepaidMaintenanceAndSupplies
91000 usd
CY2023Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
14000 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
14000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
574000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
700000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
3184000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
4164000 usd
CY2023Q3 us-gaap Assets
Assets
24829000 usd
CY2022Q4 us-gaap Assets
Assets
26729000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
462000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
397000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
230000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
173000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
698000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
967000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
262000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
245000 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1299000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1126000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2951000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2908000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
348000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
521000 usd
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2066000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2986000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
5365000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
6415000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
47500000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
47500000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25804000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25784000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23973000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23973000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
26000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
24000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
217946000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
203585000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-198505000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-183295000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
19464000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20314000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24829000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26729000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
377000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
-0 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
-0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
-0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
81000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
2000 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
296000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3305000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2743000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9533000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7515000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1683000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1567000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5200000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4882000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
365000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
347000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1147000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1019000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
5353000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
4657000 usd
us-gaap Operating Expenses
OperatingExpenses
15880000 usd
us-gaap Operating Expenses
OperatingExpenses
13416000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5353000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4655000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-15880000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-13120000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
177000 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
113000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
528000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
151000 usd
CY2023Q3 ATOM Accretion Income
AccretionIncome
112000 usd
CY2022Q3 ATOM Accretion Income
AccretionIncome
0 usd
ATOM Accretion Income
AccretionIncome
221000 usd
ATOM Accretion Income
AccretionIncome
0 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
47000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
60000 usd
us-gaap Interest Expense
InterestExpense
151000 usd
us-gaap Interest Expense
InterestExpense
200000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
72000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
72000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
314000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
53000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
670000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-49000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5039000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4602000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15210000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13169000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25255000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23294000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24536000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23029000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25255000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23294000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24536000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23029000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5039000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4602000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15210000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13169000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-1000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
0 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-3000 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
0 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5040000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4602000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15213000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13169000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
20314000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
927000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
39000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
274000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5019000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-2000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
16533000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1030000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
39000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10789000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5152000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
23239000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1041000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
39000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
185000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5039000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-1000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
19464000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
28381000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
726000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
166000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4086000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
25187000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
859000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
185000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4481000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
21750000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
889000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
39000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4603000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4602000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
22679000 usd
us-gaap Net Income Loss
NetIncomeLoss
-15210000 usd
us-gaap Net Income Loss
NetIncomeLoss
-13169000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
60000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
58000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
159000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
149000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
865000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
938000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2998000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2474000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-198000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
13000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-26000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
288000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
65000 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
186000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
57000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-269000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
193000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-189000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-125000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11649000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9581000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26000 usd
ATOM Purchase Of Availableforsale Securities
PurchaseOfAvailableforsaleSecurities
16595000 usd
ATOM Purchase Of Availableforsale Securities
PurchaseOfAvailableforsaleSecurities
-0 usd
ATOM Maturity Of Availableforsale Securities
MaturityOfAvailableforsaleSecurities
9000000 usd
ATOM Maturity Of Availableforsale Securities
MaturityOfAvailableforsaleSecurities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7626000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26000 usd
ATOM Proceeds From At The Market Sale Of Stock
ProceedsFromAtTheMarketSaleOfStock
11248000 usd
ATOM Proceeds From At The Market Sale Of Stock
ProceedsFromAtTheMarketSaleOfStock
4788000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
117000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
205000 usd
ATOM Payments On Principal Of Financing Lease
PaymentsOnPrincipalOfFinancingLease
632000 usd
ATOM Payments On Principal Of Financing Lease
PaymentsOnPrincipalOfFinancingLease
798000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10733000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4195000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8542000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5412000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21184000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28699000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12642000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23287000 usd
us-gaap Interest Paid Net
InterestPaidNet
151000 usd
us-gaap Interest Paid Net
InterestPaidNet
200000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80E_eus-gaap--NatureOfOperations_zrGxDfOlRcSa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-size: 10pt"><b>1.</b></span></td> <td><span style="font-size: 10pt"><b><span id="xdx_823_z61WHiRmllSj">NATURE OF OPERATIONS</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Atomera Incorporated (“Atomera” or the “Company”) was incorporated in the state of Delaware in March 2007 under the name MEARS Technologies, Inc. and is engaged in the development, commercialization and licensing of proprietary processes and technologies for the semiconductor industry. On January 12, 2016, the Company changed its name to Atomera Incorporated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Atomera is an early-stage company, having only recently begun limited revenue-generating activities, and is devoting substantially all its efforts toward technology research and development and to commercially licensing its technology to designers and manufacturers of integrated circuits.</p>
CY2023Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
20400000 usd
CY2023Q3 ATOM Working Capital
WorkingCapital
17900000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3851000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3422000 shares
us-gaap Lessee Operating Lease Option To Terminate
LesseeOperatingLeaseOptionToTerminate
The Company terminated its office lease in Cambridge, Massachusetts as of March 31, 2023. The cost of the lease was $2,942 per month.
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
377000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
377000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
284000 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
300000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
865000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
938000 usd
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
47000 usd
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
60000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
151000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
200000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
331000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
360000 usd
us-gaap Lease Cost
LeaseCost
1016000 usd
us-gaap Lease Cost
LeaseCost
1138000 usd
CY2023Q3 ATOM Fixed Lease Costs
FixedLeaseCosts
66000 usd
CY2022Q3 ATOM Fixed Lease Costs
FixedLeaseCosts
62000 usd
ATOM Fixed Lease Costs
FixedLeaseCosts
192000 usd
ATOM Fixed Lease Costs
FixedLeaseCosts
186000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Variable Lease Cost
VariableLeaseCost
1000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
251000 usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
9000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
792000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
29000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
318000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
71000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
985000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
215000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
55000 usd
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
53000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
216000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
161000 usd
CY2023Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
300000 usd
CY2022Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
280000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
782000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
998000 usd
CY2023Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
33000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q3 ATOM Remeasurement Of Rightofuse Asset And Liability In Financing Lease
RemeasurementOfRightofuseAssetAndLiabilityInFinancingLease
-114000 usd
CY2022Q3 ATOM Remeasurement Of Rightofuse Asset And Liability In Financing Lease
RemeasurementOfRightofuseAssetAndLiabilityInFinancingLease
-458000 usd
ATOM Remeasurement Of Rightofuse Asset And Liability In Financing Lease
RemeasurementOfRightofuseAssetAndLiabilityInFinancingLease
-114000 usd
ATOM Remeasurement Of Rightofuse Asset And Liability In Financing Lease
RemeasurementOfRightofuseAssetAndLiabilityInFinancingLease
-458000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0548 pure
CY2023Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0525 pure
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2023Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y9M18D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1900000 shares
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1041000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
889000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2998000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2474000 usd

Files In Submission

Name View Source Status
atom-20230930_cal.xml Edgar Link unprocessable
0001683168-23-007564-index-headers.html Edgar Link pending
0001683168-23-007564-index.html Edgar Link pending
0001683168-23-007564.txt Edgar Link pending
0001683168-23-007564-xbrl.zip Edgar Link pending
atom-20230930.xsd Edgar Link pending
atomera_ex3101.htm Edgar Link pending
atomera_ex3102.htm Edgar Link pending
atomera_ex3201.htm Edgar Link pending
atomera_i10q-093023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
atom-20230930_def.xml Edgar Link unprocessable
atom-20230930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
atom-20230930_pre.xml Edgar Link unprocessable
atomera_i10q-093023_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending